share_log

Tonix Pharmaceuticals CEO Seth Lederman Discloses Purchase Of 20,000 Shares Of Co.'s Common Stock At An Average Price Of $1.71/Share

Benzinga Real-time News ·  Jul 2, 2022 04:10
Tonix Pharmaceuticals CEO Seth Lederman Discloses Purchase Of 20,000 Shares Of Co.'s Common Stock At An Average Price Of $1.71/Share
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment